Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolaj Juul Nitschke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|October 28, 2021
[Germ line predisposition for myeloid neoplasia in adults]Nikolaj Juul Nitschke, Mette Klarskov Andersen, Kirsten Grønbæk
Cancer Epidemiology|January 10, 2024
Risk of cancer in relatives of patients with myelodysplastic neoplasia and acute leukemiasNikolaj Juul Nitschke, Klaus Rostgaard, Mette Klarskov Andersen, et al.
Stem Cell Investigation|October 24, 2017
Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanomaNikolaj Juul Nitschke, Jon Bjoern, Trine Zeeberg Iversen, et al.
Cytotherapy|July 6, 2016
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumabJon Bjoern, Trine Zeeberg Iversen, Nikolaj Juul Nitschke, et al.
Oncoimmunology|May 4, 2016
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with IpilimumabJon Bjoern, Nikolaj Juul Nitschke, Trine Zeeberg Iversen, et al.
Clinical Genetics|April 12, 2024
Expanding the understanding of telomere biology disorder with reports from two families harboring variants in ZCCHC8 and TERCNikolaj Juul Nitschke, Anne Marie Jelsig, Charlotte Lautrup, et al.
Human Mutation|April 14, 2025
Frequency and Functional Characterization of <i>RUNX1</i> Germline Variants in Myeloid NeoplasmsNikolaj Juul Nitschke, Marwa Almosailleakh, Yiyuan Niu, et al.
Human Mutation|June 29, 2026
Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based MethodNikolaj Juul Nitschke, Marwa Almosailleakh, Issa Ismail Issa, et al.
American Journal of Hematology|June 24, 2026
Mosaic Chromosomal Alterations Identify Ultra-High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive ChemotherapyMathias Æ Heldbo, Kirstine Ostenfeld Larsen, Nikolaj Juul Nitschke, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|October 28, 2021
[Germ line predisposition for myeloid neoplasia in adults]Nikolaj Juul Nitschke, Mette Klarskov Andersen, Kirsten Grønbæk
Cancer Epidemiology|January 10, 2024
Risk of cancer in relatives of patients with myelodysplastic neoplasia and acute leukemiasNikolaj Juul Nitschke, Klaus Rostgaard, Mette Klarskov Andersen, et al.
Stem Cell Investigation|October 24, 2017
Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanomaNikolaj Juul Nitschke, Jon Bjoern, Trine Zeeberg Iversen, et al.
Cytotherapy|July 6, 2016
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumabJon Bjoern, Trine Zeeberg Iversen, Nikolaj Juul Nitschke, et al.
Oncoimmunology|May 4, 2016
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with IpilimumabJon Bjoern, Nikolaj Juul Nitschke, Trine Zeeberg Iversen, et al.
Clinical Genetics|April 12, 2024
Expanding the understanding of telomere biology disorder with reports from two families harboring variants in ZCCHC8 and TERCNikolaj Juul Nitschke, Anne Marie Jelsig, Charlotte Lautrup, et al.
Human Mutation|April 14, 2025
Frequency and Functional Characterization of <i>RUNX1</i> Germline Variants in Myeloid NeoplasmsNikolaj Juul Nitschke, Marwa Almosailleakh, Yiyuan Niu, et al.
Human Mutation|June 29, 2026
Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based MethodNikolaj Juul Nitschke, Marwa Almosailleakh, Issa Ismail Issa, et al.
American Journal of Hematology|June 24, 2026
Mosaic Chromosomal Alterations Identify Ultra-High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive ChemotherapyMathias Æ Heldbo, Kirstine Ostenfeld Larsen, Nikolaj Juul Nitschke, et al.
Pageof 1